Fernando M de Benedictis

Summary

Country: Italy

Publications

  1. ncbi Use of inhaler devices in pediatric asthma
    Fernando Maria de Benedictis
    Department of Pediatrics, Salesi Children s Hospital, Ancona, Italy
    Paediatr Drugs 5:629-38. 2003
  2. doi Amino-terminal pro-B-type natriuretic peptide in refractory Kawasaki disease
    Fernando Maria de Benedictis
    Department of Pediatrics, Salesi Children s Hospital, Azienda Ospedaliero Universitaria Ospedali Riuniti, Ancona, Italy
    Pediatr Cardiol 30:837-9. 2009
  3. doi Montelukast sodium for exercise-induced asthma
    Fernando Maria de Benedictis
    Department of Pediatrics, Salesi Children s Hospital, Ancona, Italy
    Drugs Today (Barc) 44:845-55. 2008
  4. doi Aspiration lung disease
    Fernando M de Benedictis
    Division of Pediatric Medicine, Department of Pediatrics, Salesi Children s University Hospital, Ancona, Italy
    Pediatr Clin North Am 56:173-90, xi. 2009
  5. doi Necrotising fasciitis complicating varicella
    F M de Benedictis
    Department of Pediatrics, Salesi Children s Hospital, Ancona, Italy
    Arch Dis Child 93:619. 2008
  6. ncbi Lack of tolerance to the protective effect of montelukast in exercise-induced bronchoconstriction in children
    F M de Benedictis
    Dept of Paediatrics, University of Perugia, Italy
    Eur Respir J 28:291-5. 2006
  7. ncbi Nebulized fluticasone propionate vs. budesonide as adjunctive treatment in children with asthma exacerbation
    Fernando Maria de Benedictis
    Clinica Pediatrica, Universita di Perugia, Italy
    J Asthma 42:331-6. 2005
  8. ncbi Cough, wheezing and asthma in children: lesson from the past
    Fernando Maria de Benedictis
    Department of Pediatric Medicine, Salesi Childrens Hospital, Ancona, Italy
    Pediatr Allergy Immunol 15:386-93. 2004
  9. pmc Exhaled nitric oxide measurements in the first 2 years of life: methodological issues, clinical and epidemiological applications
    Carmelo Gabriele
    Department of Pediatrics, Salesi Children s Hospital, Azienda Ospedaliero Universitaria Ospedali Riuniti, Ancona, Italy
    Ital J Pediatr 35:21. 2009
  10. doi Corticosteroids in respiratory diseases in children
    Fernando M de Benedictis
    Department of Mother and Child Health, Salesi Children s Hospital, Ancona, Italy
    Am J Respir Crit Care Med 185:12-23. 2012

Collaborators

Detail Information

Publications11

  1. ncbi Use of inhaler devices in pediatric asthma
    Fernando Maria de Benedictis
    Department of Pediatrics, Salesi Children s Hospital, Ancona, Italy
    Paediatr Drugs 5:629-38. 2003
    ..Thus, the choice of a delivery device mainly depends on the age of the patient, the drug to be administered and the condition to be treated. Proper education is also essential when prescribing an inhalation device...
  2. doi Amino-terminal pro-B-type natriuretic peptide in refractory Kawasaki disease
    Fernando Maria de Benedictis
    Department of Pediatrics, Salesi Children s Hospital, Azienda Ospedaliero Universitaria Ospedali Riuniti, Ancona, Italy
    Pediatr Cardiol 30:837-9. 2009
    ..The regular evaluation of this cardiac biomarker after infliximab treatment may have clinical relevance in patients with refractory Kawasaki disease and severe heart involvement...
  3. doi Montelukast sodium for exercise-induced asthma
    Fernando Maria de Benedictis
    Department of Pediatrics, Salesi Children s Hospital, Ancona, Italy
    Drugs Today (Barc) 44:845-55. 2008
    ..This aspect is particularly relevant for children, who tend to be active at frequent and irregular intervals throughout the day, and who therefore may benefit from around-the-clock pharmacologic protection...
  4. doi Aspiration lung disease
    Fernando M de Benedictis
    Division of Pediatric Medicine, Department of Pediatrics, Salesi Children s University Hospital, Ancona, Italy
    Pediatr Clin North Am 56:173-90, xi. 2009
    ..Many children are still not adequately diagnosed or treated for aspiration until permanent lung damage has occurred. A multidisciplinary approach is mandatory for a correct diagnosis in addition to timely and appropriate care...
  5. doi Necrotising fasciitis complicating varicella
    F M de Benedictis
    Department of Pediatrics, Salesi Children s Hospital, Ancona, Italy
    Arch Dis Child 93:619. 2008
  6. ncbi Lack of tolerance to the protective effect of montelukast in exercise-induced bronchoconstriction in children
    F M de Benedictis
    Dept of Paediatrics, University of Perugia, Italy
    Eur Respir J 28:291-5. 2006
    ..Regular treatment with montelukast provided significant protection against exercise-induced bronchoconstriction in asthmatic children over a 4-week period with no tolerance to the bronchoprotective effect...
  7. ncbi Nebulized fluticasone propionate vs. budesonide as adjunctive treatment in children with asthma exacerbation
    Fernando Maria de Benedictis
    Clinica Pediatrica, Universita di Perugia, Italy
    J Asthma 42:331-6. 2005
    ..To compare the effects of nebulized fluticasone propionate (FP) and nebulized budesonide (BUD) in addition to inhaled salbutamol in children with mild asthma exacerbation...
  8. ncbi Cough, wheezing and asthma in children: lesson from the past
    Fernando Maria de Benedictis
    Department of Pediatric Medicine, Salesi Childrens Hospital, Ancona, Italy
    Pediatr Allergy Immunol 15:386-93. 2004
    ..e., in a primary care setting or ain a specialistic clinic) may address doctors to the right diagnosis. A prudent ''wait and see'' approach may be useful in many occasions...
  9. pmc Exhaled nitric oxide measurements in the first 2 years of life: methodological issues, clinical and epidemiological applications
    Carmelo Gabriele
    Department of Pediatrics, Salesi Children s Hospital, Azienda Ospedaliero Universitaria Ospedali Riuniti, Ancona, Italy
    Ital J Pediatr 35:21. 2009
    ....
  10. doi Corticosteroids in respiratory diseases in children
    Fernando M de Benedictis
    Department of Mother and Child Health, Salesi Children s Hospital, Ancona, Italy
    Am J Respir Crit Care Med 185:12-23. 2012
    ..These have been reduced, but not eliminated, with the use of the inhaled route. The benefits must be weighed against the potential detrimental effects...